Cargando…
Immunotherapy with Cell-Based Biological Drugs to Cure HIV-1 Infection
Since its discovery 35 years ago, there have been no therapeutic interventions shown to enable full HIV-1 remission. Combined antiretroviral therapy (cART) has achieved the sustained control of HIV-1 replication, however, the life-long treatment does not eradicate long-lived latently infected reserv...
Autores principales: | Siracusano, Gabriel, Lopalco, Lucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750418/ https://www.ncbi.nlm.nih.gov/pubmed/35011639 http://dx.doi.org/10.3390/cells11010077 |
Ejemplares similares
-
Cell Surface Proteins in Hepatocellular Carcinoma: From Bench to Bedside
por: Siracusano, Gabriel, et al.
Publicado: (2020) -
Opportunities for CAR-T Cell Immunotherapy in HIV Cure
por: Campos-Gonzalez, Gerard, et al.
Publicado: (2023) -
HIV-1 Env Does Not Enable the Development of Protective Broadly Neutralizing Antibodies in an Experimental Autoimmune Encephalomyelitis Mouse Model
por: Siracusano, Gabriel, et al.
Publicado: (2021) -
Humoral Immune Responses in COVID-19 Patients: A Window on the State of the Art
por: Siracusano, Gabriel, et al.
Publicado: (2020) -
Natural anti-CCR5 antibodies in HIV-infection and -exposure
por: Lopalco, Lucia
Publicado: (2011)